111 Long Term Debt 2018-2023 | YI
111 long term debt from 2018 to 2023. Long term debt can be defined as the sum of all long term debt fields.
| 111 Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 111 Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-09-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.095B | $2.105B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.069B | 20.90 |
| Inspire Medical Systems (INSP) | United States | $4.986B | 0.00 |
| Axonics (AXNX) | United States | $3.440B | 0.00 |
| 10x Genomics (TXG) | United States | $3.097B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.080B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.900B | 0.00 |
| Azenta (AZTA) | United States | $2.877B | 156.36 |
| Enovis (ENOV) | United States | $2.801B | 20.76 |
| Hims & Hers Health (HIMS) | United States | $2.633B | 0.00 |
| Privia Health (PRVA) | United States | $2.132B | 119.80 |
| Schrodinger (SDGR) | United States | $1.644B | 0.00 |
| Omnicell (OMCL) | United States | $1.383B | 47.81 |
| Phreesia (PHR) | United States | $1.205B | 0.00 |
| Standard BioTools (LAB) | United States | $0.696B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.627B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.406B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.378B | 0.00 |
| Pulmonx (LUNG) | United States | $0.326B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.306B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.215B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Outset Medical (OM) | United States | $0.159B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 7.07 |
| MSP Recovery (LIFW) | United States | $0.121B | 0.00 |
| Augmedix (AUGX) | United States | $0.109B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.078B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |